|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
36.600 -0.250 (-0.678%) Ranking Overview
Ranking based on 1 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2019 | EPS | 130.00 RMB (cts) | |
| Net Profit | 3,321.62 RMB (MIL) | DPS | 39.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2020 | 3,436.96 | 134.00 | -- | 3,436.96 | 3,436.96 | |
| 2021 | 4,189.38 | 163.00 | -- | 4,189.38 | 4,189.38 | |
| 2022 | 5,657.77 | 221.00 | -- | 5,657.77 | 5,657.77 | |
| 2023 | 8,228.25 | 321.00 | -- | 8,228.25 | 8,228.25 | |
| 2024 | 9,431.51 | 368.00 | -- | 9,431.51 | 9,431.51 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2020 | 3,436.96 | 134.00 | -- | MORGAN STANLEY | Overweight | 40.00 | 26/08/2020 | |
| 2021 | 4,189.38 | 163.00 | -- | MORGAN STANLEY | -- | -- | 26/08/2020 | |
| 2022 | 5,657.77 | 221.00 | -- | MORGAN STANLEY | -- | -- | 26/08/2020 | |
| 2023 | 8,228.25 | 321.00 | -- | MORGAN STANLEY | -- | -- | 26/08/2020 | |
| 2024 | 9,431.51 | 368.00 | -- | MORGAN STANLEY | -- | -- | 26/08/2020 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 26/02/2021 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,714,710 |
| %Change | 13.099% |
| EPS / (LPS) | RMB 0.670 |
| NBV Per Share (¥) | RMB 12.869 |